fda tirzepatide update today confirms shortage is still over, gives compounders a grace period FDA says the tirzepatide weight-loss

These are linked to the same melanocortin pathways that affect the brain

Now another drug called Mounjaro has been added to the race, and although it has not yet received FDA approval, but the approval process is underway

10.1073/pnas.1316569111 Summary Keywords TMA, TMAU, TMAO, CVD, postbiotic, rare disease, tyndallized Citation Giannini G, Soldi S, Elli M, Sagheddu V, Castagnetti A, Viciani E, Salvini L, Battistuzzi G, Milazzo FM, Alibrandi S and Sidoti A (2025) A mixture of postbiotics/tyndallized probiotics reduces trimethylamine (TMA) in trimethylaminuria models: Evidence from in vitro and in vivo studies

Grossmann M, Matsumoto AM